HY-16988A-2mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
HY-16988A-5mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
HY-16988A-50mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
HY-16988A-1mL
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-16988-10mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
HY-16988-100mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
HY-16988-2mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
HY-16988-5mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
HY-16988-50mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
HY-16988-1mL
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-10426-10mg
|
MedChemexpress LLC
|
XCT790 [CAS 725247-18-7]
|
|
Cancer-programmed cell death
|
|
HY-10426-5mg
|
MedChemexpress LLC
|
XCT790 [CAS 725247-18-7]
|
|
Cancer-programmed cell death
|
|
HY-10426-50mg
|
MedChemexpress LLC
|
XCT790 [CAS 725247-18-7]
|
|
Cancer-programmed cell death
|
|
HY-10426-1mL
|
MedChemexpress LLC
|
XCT790 [CAS 725247-18-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|